[A phase I study of subcutaneous envafolimab (KN035) monotherapy in Chinese patients with advanced solid tumors].
Liu RR, Gu SZ, Zhou T, Lin LZ, Chen WC, Zhong DS, Liu TS, Yang N, Shen L, Xu SY, Lu N, Zhang Y, Gong ZL, Xu JM.
Liu RR, et al. Among authors: zhou t.
Zhonghua Zhong Liu Za Zhi. 2023 Oct 23;45(10):898-903. doi: 10.3760/cma.j.cn112152-20220530-00373.
Zhonghua Zhong Liu Za Zhi. 2023.
PMID: 37875426
Clinical Trial.
Chinese.